510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1426-2017Class II

DR Systems Unity PACS software, now known as Merge Unity PACS

Merge Healthcare Incorporated / initiated 2016-04-08 / Terminated / root cause: software

Merge Healthcare, Inc. began a recall of DR Systems Unity PACS software, now known as Merge Unity PACS on . FDA classified it as Class II and gives the reason as "Reports were missing demographic header information when they were faxed to referring physicians". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1426-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Merge Healthcare Incorporated
Product
DR Systems Unity PACS software, now known as Merge Unity PACS
Product code
LLZ System, Image Processing, Radiological
Reason for recall
Reports were missing demographic header information when they were faxed to referring physicians.
Root cause tag
software
FDA root cause
Software design
Action
Merge sent an Urgent : Medical Device Recall letter dated March 28, 2016, to all affected customers via email on April 8, 2016. Nonresponders were issued a second letter dated July 11, 2016. The letter notifies the customer of the issue, makes them aware of a workaround, and informs them a fix is available. The notification instructs the customer to pass the information onto all other users, as well as any downstream customers if it was further distributed. The notification also informs the customer their response is required using the enclosed form and the return addressed envelope. The response form asks, in part, if they are interested in accepting the fix. If they decline the fix, they are asked to provide the reason why. The response was required no later than April 18, 2016. Nonresponders were issued a second letter dated July 11, 2016, asking for a response by August 8, 2016. The letter and response form contained the same information as the first letter. If the second letter results in additional unresponsive customers, a call campaign will be managed by Customer Support and documented via SalesForce. Three call attempts will made before closing the case. The recalling firm reported emails will be tracked for delivery confirmation. For further questions please call ( 877) 741-5369.
Quantity in commerce
9 sites potentially have the affected version
Distribution
US Distribution was made to medical facilities in CA, MT, PA, and TX. There was no foreign/military/government distribution.
Product codes and lots
Version 11.0

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1426-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1426-2017Class IITerminatedVoluntary: Firm initiated